Abvc Biopharma (ABVC) Common Equity (2010 - 2026)
Abvc Biopharma (ABVC) posted Common Equity of $12.27 million for Q2 2026, up 29.3% from $9.49 million a year earlier but down 4.4% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Common Equity came in at $13.3 million.
- Annual Common Equity shows a five-year compound annual growth rate of 37.9% (FY2020 to FY2025).
- In prior years, Abvc Biopharma's Common Equity was $723,959 in FY2024 (-42.2%), $1.25 million in FY2023 (-61.3%), $3.24 million in FY2022 (-63.5%) and $8.87 million in FY2021 (+233.2%).
- Quarterly Common Equity has run from a low of $723,959 in Q4 2024 to a high of $14.5 million in Q3 2025 over five years.
- On a year-over-year basis, Common Equity increased in five of the last seven quarters, with growth averaging 244.4%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2025, with growth of 782.8%; the weakest was Q2 2023, with a decline of 85.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $12.83 million (Q1 2026), $13.3 million (Q4 2025) and $14.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Abvc Biopharma | 26.80 Mn | 27.48 Mn | - | 12.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.27 Mn |
| Mar 31, 2026 | 12.83 Mn |
| Dec 31, 2025 | 13.30 Mn |
| Sep 30, 2025 | 14.50 Mn |
| Jun 30, 2025 | 9.49 Mn |
| Mar 31, 2025 | 7.96 Mn |
| Dec 31, 2024 | 723,959.00 |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 9.06 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 3.24 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 9.18 Mn |
| Mar 31, 2022 | 7.36 Mn |
| Dec 31, 2021 | 8.87 Mn |
| Sep 30, 2021 | 7.59 Mn |
API Access
Abvc Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();